RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$696M
AUM Growth
+$65M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$13.8M
3
+$10.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.96M
5
SNY icon
Sanofi
SNY
+$7.67M

Top Sells

1
+$11.2M
2
+$10.8M
3
+$8.62M
4
ESPR icon
Esperion Therapeutics
ESPR
+$8.33M
5
BIIB icon
Biogen
BIIB
+$5.29M

Sector Composition

1 Healthcare 92.59%
2 Financials 0.93%
3 Technology 0.13%
4 Energy 0.1%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$5.48M 0.79%
259,556
-444
52
$5.36M 0.77%
213,901
+60,000
53
$4.99M 0.72%
6,174
54
$4.98M 0.71%
26,468
-11,000
55
$4.78M 0.69%
650,000
56
$4.68M 0.67%
529,610
+50,000
57
$4.62M 0.66%
95,000
-20,000
58
$4.36M 0.63%
25,000
-15,000
59
$4.29M 0.62%
55,000
-20,000
60
$4.25M 0.61%
45,000
-18,000
61
$4.06M 0.58%
94,231
-4,306
62
$3.98M 0.57%
50,000
-22,659
63
$3.94M 0.57%
75,000
-10,000
64
$3.9M 0.56%
99,000
-81,000
65
$3.81M 0.55%
+252,136
66
$3.76M 0.54%
137,590
+9,390
67
$3.56M 0.51%
55,000
68
$3.56M 0.51%
425,000
+75,000
69
$3.39M 0.49%
75,000
70
$3.18M 0.46%
70,000
-80,000
71
$3.1M 0.44%
277,303
-125,000
72
$3.08M 0.44%
23,280
-1,804
73
$3.07M 0.44%
425,111
74
$3.06M 0.44%
175,000
75
$2.42M 0.35%
168,872
+57,515
1 2
3
4 5